MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aptinyx Inc (NQ: APTX )

0.5500 -0.0079 (-1.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 392,483
Open 0.5300
Bid (Size) 0.5500 (5)
Ask (Size) 0.5750 (198)
Prev. Close 0.5579
Today's Range 0.5300 - 0.6097
52wk Range 0.3600 - 3.760
Shares Outstanding 67,715,718
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
Expert Ratings for Aptinyx
Within the last quarter, Aptinyx (NASDAQ:APTX) has observed the following analyst ratings: 
Via Benzinga

Performance

YTD
-80.07%
-80.07%
1 Month
+31.01%
+31.01%
3 Month
-78.68%
-78.68%
6 Month
-80.07%
-80.07%
1 Year
-80.63%
-80.63%

More News

Read More
Expert Ratings for Aptinyx
Via Benzinga
Aptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conference
From Aptinyx Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Aptinyx to Participate in H.C. Wainwright Global Investment Conference
From Aptinyx Inc.
Via Business Wire
Aptinyx Announces Poster Presentation Highlighting Preclinical Data on NYX-783 in Models of PTSD at the 2022 American Psychiatric Association Annual Meeting
From Aptinyx Inc.
Via Business Wire
Recap: Aptinyx Q1 Earnings
Via Benzinga
Aptinyx Reports First Quarter 2022 Financial Results and Highlights Recent Clinical Progress
From Aptinyx Inc.
Via Business Wire
90 Biggest Movers From Yesterday
Via Benzinga
Aptinyx Presents Preclinical Data on NYX-783 in Models of PTSD at 2022 Society of Biological Psychiatry Annual Meeting
From Aptinyx Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Aptinyx to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
From Aptinyx Inc.
Via Business Wire
26 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
Aptinyx Announces Publication in Molecular Psychiatry Demonstrating Reduction of Spontaneous Recovery of Fear with NYX-783
From Aptinyx Inc.
Via Business Wire
53 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: S&P 500 Turns Positive; Aptinyx Shares Slide
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Mid-Day Market Update: Dow Tumbles Over 200 Points; Momentus Shares Jump
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Mid-Morning Market Update: Markets Mixed; US Jobless Claims Fall Last Week
Via Benzinga
Aptinyx Shares Tank On Disappointed Data From Mid-Stage Diabetic Peripheral Neuropathy Study
Via Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
Via Benzinga
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
From Aptinyx Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story